← Leaderboards
Julius N. Korley
Affinity Therapeutics, Llc
$2,005,551
Attributed
$3,611,103
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,611,103 · 2
By mechanism
UT2$3,211,105 · 1
R43$399,998 · 1
Top collaborators
- John Royer3 shared
Most similar at Affinity Therapeutics, Llc
Same institution · by research overlap
- Sean T. Zuckerman$626,752
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsTranslatingTechnologySmall Business Innovation Research GrantInnovationLicensingMarketingSuccessUniversitiesExposure ToEnsureEngineeringBasic ScienceEvaluationEntrepreneurshipFailureDisclosureCessation Of LifeAwardCritical PathwaysDelawareChemistryEducational CurriculumEcosystem
Grant awards (5)
Increasing IDeA state Biomedical Entrepreneurship via Ecosystem, Enterprises & Experts$1,461,558
UT2 · FY2025 · GM
Increasing IDeA state Biomedical Entrepreneurship via Ecosystem, Enterprises & Experts$1,475,980
UT2 · FY2024 · GM
Increasing IDeA state Biomedical Entrepreneurship via Ecosystem, Enterprises & Experts$273,567
UT2 · FY2023 · GM
Cyclodextrin-based Microparticle Polymer Formulations for the Slow and Sustained$199,999
R43 · FY2013 · GM · contact PI
Cyclodextrin-based Microparticle Polymer Formulations for the Slow and Sustained$199,999
R43 · FY2012 · GM · contact PI